0000950170-24-017070.txt : 20240220
0000950170-24-017070.hdr.sgml : 20240220
20240220160022
ACCESSION NUMBER: 0000950170-24-017070
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240220
FILED AS OF DATE: 20240220
DATE AS OF CHANGE: 20240220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sprague John M
CENTRAL INDEX KEY: 0001730056
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36571
FILM NUMBER: 24653091
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVE.
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: T2 Biosystems, Inc.
CENTRAL INDEX KEY: 0001492674
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 204827488
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-457-1200
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
ownership.xml
4
X0508
4
2024-02-20
0001492674
T2 Biosystems, Inc.
TTOO
0001730056
Sprague John M
101 HARTWELL AVENUE
LEXINGTON
MA
02421
false
true
false
false
Chief Financial Officer
false
Common Stock
2024-02-20
4
M
false
40
A
112
D
Restricted Stock Units
2024-02-20
4
A
false
40
0
A
Common Stok
40
40
D
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
On February 20, 2022 the reporting person was granted 120 RSU's that vest in three equal installments commencing on February 20, 2023.
/s/ Michael Gibbs, Attorney-in-fact
2024-02-20